
If you had $5,000 ready to invest today, where would you put it?
Markets have been volatile, sentiment has swung sharply, and a number of high-quality ASX shares are still trading well below their peaks. For long-term investors, that combination can open the door to attractive opportunities.
Here are three ASX shares that could be no-brainer buys right now.
CSL Ltd (ASX: CSL)
The first ASX share that looks very attractive at current levels is biotech leader CSL.
It is not often that a company of CSL’s calibre trades at a discount, but recent headwinds have created that setup. Concerns around the underperformance of its key CSL Behring business, a sudden CEO exit, and broader market sentiment have weighed on the CSL share price.
However, these challenges appear largely short-term rather than structural. CSL remains a global leader in plasma therapies, with demand underpinned by ageing populations and rising healthcare needs. These are long-term drivers that are unlikely to change.
As its performance normalises and operational efficiencies improve, there is a clear pathway for margins to recover.
For patient investors, this could be one of those rare windows to buy a world-class business at a more attractive price.
Life360 Inc (ASX: 360)
Another ASX share that could be worth considering is location technology company Life360.
Life360 is transitioning from just a user growth story into both a monetisation and user growth story. Its platform continues to grow globally, but the focus is now on improving revenue per user through subscriptions, partnerships, and new services.
At the same time, profitability is improving as the company demonstrates operating leverage.
This is often the phase where growth companies begin to rerate, as investors gain confidence in the sustainability of earnings.
If that shift in perception continues, the current share price may prove to be an attractive entry point.
WiseTech Global Ltd (ASX: WTC)
A final ASX share that could be a strong buy is WiseTech Global.
WiseTech is building what is increasingly becoming the operating system for global logistics. Its CargoWise platform is deeply embedded across supply chains, making it highly difficult for customers to replace.
The interesting part of the story right now is not the business itself, but how it is being priced.
Like many growth names, WiseTech has experienced volatility as investors reassess valuations and consider the impact of emerging technologies. Yet the company continues to expand globally, win larger customers, and deepen its product suite.
With logistics becoming more complex and digitised, WiseTech’s long-term opportunity remains substantial.
The post $5,000 to invest? 3 ASX shares that could be no-brainer buys right now appeared first on The Motley Fool Australia.
Should you invest $1,000 in Life360 right now?
Before you buy Life360 shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Life360 wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why are Life360 shares sliding to fresh lows today?
- 5 ASX 200 shares that could be a bargain right now
- Better buy? CSL vs Rio Tinto shares
- How to build a winning 10 ASX share portfolio from scratch in 2026
- Buy, hold, sell: Life360, Northern Star, and Sigma shares
Motley Fool contributor James Mickleboro has positions in CSL, Life360, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Life360, and WiseTech Global. The Motley Fool Australia has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.